InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (2 ops.)
Discover the complete record of transactions filed by RUBINSTEIN JULIE, Chief Operating Officer. Officer active across 1 companies, notably Adaptive Biotechnologies Corp. In total, 27 reports have been logged. Total volume traded: €2.8m. The latest transaction was filed on 22 April 2026 — Levée d'options. Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations27 total
US$106,39614,722 shares@ US$7.2270.0052% mcap4.3% of flow
Common Stock
SEC:0001780664-26-000030·
€106,39614,722 shares@ €7.2270.0052% mcap2.1% of flow
Common Stock
SEC:0001780664-26-000030:0·
US$105,70414,722 shares@ US$7.180.0051% mcap4.2% of flow
Common Stock
SEC:0001780664-26-000028·
€105,70414,722 shares@ €7.180.0051% mcap2.1% of flow
Common Stock
SEC:0001780664-26-000028:0·
US$105,55514,722 shares@ US$7.16990.0051% mcap4.2% of flow
Common Stock
SEC:0001780664-26-000026·
€105,55514,722 shares@ €7.16990.0051% mcap2.1% of flow
Common Stock
SEC:0001780664-26-000026:0·
US$91,54614,722 shares@ US$6.21830.0045% mcap3.7% of flow
Common Stock
SEC:0001780664-26-000024·
€91,54614,722 shares@ €6.21830.0045% mcap1.8% of flow
Common Stock
SEC:0001780664-26-000024:0·
US$92,73614,722 shares@ US$6.29920.0045% mcap3.7% of flow
Common Stock
SEC:0001780664-26-000022·
€92,73614,722 shares@ €6.29920.0045% mcap1.9% of flow
Common Stock
SEC:0001780664-26-000022:0·
US$92,34114,722 shares@ US$6.27230.0045% mcap3.7% of flow
Common Stock
SEC:0001780664-26-000020·
€92,34114,722 shares@ €6.27230.0045% mcap1.8% of flow
Common Stock
SEC:0001780664-26-000020:0·
US$92,78614,722 shares@ US$6.30250.0045% mcap3.7% of flow
Common Stock
SEC:0001780664-26-000018·
€92,78614,722 shares@ €6.30250.0045% mcap1.9% of flow
Common Stock
SEC:0001780664-26-000018:0·
US$92,21014,722 shares@ US$6.26340.0045% mcap3.7% of flow
Common Stock
SEC:0001780664-26-000016·
€92,21014,722 shares@ €6.26340.0045% mcap1.8% of flow
Common Stock
SEC:0001780664-26-000016:0·
US$84,11114,722 shares@ US$5.71330.0041% mcap3.4% of flow
Common Stock
SEC:0001780664-26-000014·
€84,11114,722 shares@ €5.71330.0041% mcap1.7% of flow
Common Stock
SEC:0001780664-26-000014:0·
US$84,32714,722 shares@ US$5.7280.0041% mcap3.4% of flow
Common Stock
SEC:0001780664-26-000012·
€84,32714,722 shares@ €5.7280.0041% mcap1.7% of flow
Common Stock
SEC:0001780664-26-000012:0·
US$1m122,523 shares@ US$11.34240.068% mcap55.5% of flow
Common Stock
SEC:0001780664-26-000008·
€1m122,523 shares@ €11.34240.068% mcap27.8% of flow
Common Stock
SEC:0001780664-26-000008:0·
US$83,07114,722 shares@ US$5.64260.0040% mcap3.3% of flow
Common Stock
SEC:0001780664-26-000006·
€83,07114,722 shares@ €5.64260.0040% mcap1.7% of flow
Common Stock
SEC:0001780664-26-000006:0·
US$82,43714,722 shares@ US$5.59960.0040% mcap3.3% of flow
Common Stock
SEC:0001780664-26-000002·
25 of 27 declarations
About RUBINSTEIN JULIE
Julie Rubinstein is the Chief Operating Officer at Adaptive Biotechnologies Corp.
